Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Diagnostic Cut-off Value of Core Biomarkers of Alzheimer's Disease
Sponsor: Capital Medical University
Summary
The participant in this study includes Alzheimer's disease (AD including familial AD and sporadic AD) patients, amnestic mild cognitive impairment (aMCI) patients, non-AD dementia patients and cognitively normal control. The purpose of this study is to establish the best cut-off value of cerebrospinal fluid (CSF) and blood β-amyloid (Aβ) 42/40, total tau (t-tau) , phosphorylated tau ,inflammatory factors, etc. in diagnosis of Alzheimer's disease (AD).
Official title: Study on the Diagnostic Cut-off Value of Core Biomarkers in Cerebrospinal Fluid and Blood of Alzheimer's Disease
Key Details
Gender
All
Age Range
55 Years - 75 Years
Study Type
OBSERVATIONAL
Enrollment
3200
Start Date
2018-09-01
Completion Date
2027-09-01
Last Updated
2026-03-23
Healthy Volunteers
Yes
Conditions
Locations (1)
Xuanwu Hospital of Capital Medical University
Beijing, Beijing Municipality, China